ArticlemedRxiv : the preprint server for health sciences2025
Neurocognition After Perturbed Sleep (NAPS): A Protocol for an Experimental Study Examining the Impact of Sleep on Neurocognition, Functioning, and Clinical Indicators in People with Schizophrenia.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Introduction: People with schizophrenia (SZ) display neurocognitive deficits that have been identified as predictors of poor functioning and disability. Previous reports have noted that these deficits are strikingly similar to the cognitive sequalae of poor sleep. Consistent with this observation, extensive animal and basic human research have strongly support the deleterious effects of poor sleep on neurocognition. Notably, insomnia and disturbed sleep (DS) are highly ubiquitous among people with SZ. Yet, there is scarce information about the potential impact of poor sleep on neurocognition in this population, with available studies using correlational or cross-sectional designs. Method: We will employ an experimental, within-person, cross-over design to characterize sleep architecture, duration, continuity and quality along with their neurocognitive, functional, electrophysiological, and clinical sequalae in individuals with SZ. Participants will complete two overnight lab-based polysomnography examinations (two weeks apart) employing two sleep schedules: 1) undisturbed sleep (8 hours); and 2) perturbed sleep (4 hours). As part of each overnight sleep schedule, participants will complete brief EEG-indexed sleep-sensitive memory tasks pre- and post-sleep, a post-sleep neurocognitive test battery, as well as a three-day post-sleep digital phenotyping of physical activity, daily functioning, mood, symptoms, medication side-effects, and suicidal ideation via smartphones and actigraphy. Discussion: Despite their chronic and ubiquitous nature, the impact of insomnia and DS on neurocognition in SZ remain poorly understood and modeled. This lack of information hinders our ability to develop accurate treatment models and effective interventions for neurocognitive deficits in SZ. Our aim is to address these gaps in knowledge.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.